Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
fluvoxamine [2022/01/14 20:00] brian | fluvoxamine [2022/05/27 18:11] (current) pamela | ||
---|---|---|---|
Line 12: | Line 12: | ||
==Story of Discovery== | ==Story of Discovery== | ||
- | [[Angela Reiersen]] was the first to propose Fluvoxamine as a treatment for Covid-19 in March 2020. | + | [[Angela Reiersen]] was the first to propose Fluvoxamine as a treatment for Covid-19 in March 2020. Reierson remembered learning about the ability of FLV to protect mice from lethal septic shock and dampen the inflammatory response in human blood leukocytes from a 2019 journal article in //Science Translational Medicine// |
The first published paper that proposed FLV's S1R agonist mechanism of action against Covid-19 was //" | The first published paper that proposed FLV's S1R agonist mechanism of action against Covid-19 was //" | ||
Line 29: | Line 29: | ||
A pre-print Meta-Analysis posted on December 21, 2021 concluded that FLV has a high probability of preventing hospitalization from Covid-19(([[https:// | A pre-print Meta-Analysis posted on December 21, 2021 concluded that FLV has a high probability of preventing hospitalization from Covid-19(([[https:// | ||
+ | ==Presentations== | ||
+ | [[https:// | ||
+ | |||
+ | Dr. [[Eric Lenze]] gave a presentation on FLV for Covid on 20 Aug 2021(([[https:// | ||
- | == Related == | + | === Related |
[[https:// | [[https:// | ||
Dr. Peter Attia describes how one of the physicians in his practice tried to prescribe fluvoxamine for a patient who had just gotten COVID. They called in the prescription to a CVS in California, and the pharmacist told them they would not fill it because it was not part of the “official COVID guideline.” | Dr. Peter Attia describes how one of the physicians in his practice tried to prescribe fluvoxamine for a patient who had just gotten COVID. They called in the prescription to a CVS in California, and the pharmacist told them they would not fill it because it was not part of the “official COVID guideline.” | ||
Line 37: | Line 41: | ||
Finding a possible early treatment for COVID-19 in a 40-year-old antidepressant]]** | Finding a possible early treatment for COVID-19 in a 40-year-old antidepressant]]** | ||
- | ===Presentations=== | ||
- | [[https:// | ||
- | Dr. [[Eric Lenze]] gave a presentation on FLV for Covid on 20 Aug 2021(([[https://dcricollab.dcri.duke.edu/ | + | ==== The TOGETHER Study on Fluvoxamine Was Not Free of Errors, Either ==== |
+ | A First Look at the Numbers by Alexandros Marinos | ||
+ | |||
+ | This article is part of a series on the [[:TOGETHER trial]]. More articles from this series here.((https://doyourownresearch.substack.com/p/together-trial-index-of-articles? | ||
+ | |||
+ | Today, I'll show you one more example of how the TOGETHER trial outputs seem quite willing to blur various boundaries, | ||
+ | |||
+ | In a way, you can see this as a demonstration of how tugging at a fairly small thing that looks strange can unearth a whole world of concerning issues about a trial. So let’s see ((https:// | ||